Related Experiment Video

Updated: Jun 8, 2026

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation
23:33

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation

Published on: February 28, 2012

Stroke prevention in the high-risk atrial fibrillation patient: Medical management

Michael Broukhim1, Jonathan L Halperin

  • 1The Cardiovascular Institute, Mount Sinai Medical Center, New York, NY 10029, USA.

Current Cardiology Reports
|October 19, 2010
PubMed

Insights

Managing atrial fibrillation (AF) stroke risk is challenging due to imperfect risk assessment tools. New anticoagulants and interventions offer promise, especially for high-risk patients.

Area of Science:

  • Cardiology
  • Thrombosis Management
  • Clinical Practice Guidelines

Background:

  • Medical management for atrial fibrillation (AF) stroke prevention faces challenges with risk assessment tools for thromboembolism and bleeding.
  • Current European guidelines incorporate risk scores like CHA₂DS₂VASc and HAS-BLED.
  • Vitamin K antagonists have been the standard, but new options are emerging.

Purpose of the Study:

  • To review current and emerging strategies for stroke prevention in atrial fibrillation patients.
  • To highlight the need for focused evaluation of new therapies in high-risk AF populations.
  • To address limitations in current treatment options for complex AF cases.

Main Methods:

  • Review of existing literature and clinical practice guidelines.
  • Analysis of risk stratification scores (CHA₂DS₂VASc, HAS-BLED).
  • Discussion of novel anticoagulants, antiarrhythmic drugs, and interventional techniques.

Main Results:

  • Improved risk stratification tools are available but imperfect.
  • New oral anticoagulants, antiarrhythmic drugs, and left atrial appendage occlusion show promise.
  • Significant data gaps exist for high-risk AF patients.

Conclusions:

  • Stroke prevention in AF requires better risk assessment and tailored therapies.
  • Emerging treatments offer new hope but need rigorous evaluation in challenging patient groups.
  • Further research is crucial for optimizing AF management in high-risk individuals.

More Related Videos

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation28:13

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation

Published on: February 26, 2013

Related Concept Videos

Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
Dysrhythmias VI: Management of Dysrhythmias01:25

Dysrhythmias VI: Management of Dysrhythmias

Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...